In normal development, ASCL1 is expressed in the bridge cell population, the developmental intermediate group of cells that arises between schwann cell precursors and chromaffin cells, indicating that it acts at a pivotal point in the course of both normal development of this lineage and also in cancer progression (Jansky et al., 2021; Ponzoni et al., 2022). Here, ASCL1 is linked to cancer.